Novo Nordisk, the Danish drugmaker behind some of the world's best-known medicines, has been hit by a cyberattack — and is now being extorted by the people who claim responsibility for it.
According to Endpoints News, a group claiming responsibility for the breach says it stole some of Novo Nordisk's most valuable assets, including the company's artificial intelligence models and its manufacturing recipes. Endpoints describes the company as having "got robbed" and now sitting in the "unenviable position" of being extorted by the thieves.
The stolen material, as described by the group, strikes at the heart of how a modern pharmaceutical company operates. AI models can represent years of research investment and competitive advantage, guiding everything from drug discovery to production. Manufacturing recipes — the precise instructions for making a drug at scale — are among the most closely guarded trade secrets in the industry, because they are difficult and expensive to develop and reproduce.
It is important to note that the claims about what was taken come from the attackers themselves, as reported by Endpoints News. The source item does not detail how the breach occurred, when it happened, or what specific demands the extortionists have made.
Why it matters: if attackers truly hold a major drugmaker's AI systems and production know-how, the breach goes beyond a typical data leak — it threatens the core intellectual property and competitive edge that underpin the company's business, and signals how high the stakes have become as hackers increasingly target the pharmaceutical industry.